癒着バリアの世界市場予測(〜2025):製品別(再生セルロース、ヒアルロン酸、ポリエチレングリコール、フィブリン、コラーゲン、タンパク質)、種類別(フィルム、ジェル、液体)、用途別(腹部、整形外科、心臓血管、婦人科手術)

◆英語タイトル:Adhesion Barrier Market by Product (Regenerated Cellulose, Hyaluronic Acid, Polyethylene Glycol, Fibrin, Collagen & Protein), Type (Film, Gel, Liquid), Application (Abdominal, Orthopedic, Cardiovascular, Gynecological Surgery) - Global Forecast to 2025
◆商品コード:MD 4492
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2020年10月20日
◆ページ数:197
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥534,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Marketsandmarkets社は癒着バリアの世界市場が2020年529百万ドルから2025年769百万ドルまで、年平均7.8%成長すると展望しています。本調査レポートでは、癒着バリアの世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、市場インサイト、製品別(合成癒着バリア、天然癒着バリア)分析、剤型別(フィルム製剤、液剤、ゲル製剤)分析、用途別(婦人科手術、一般/腹部手術、心臓血管手術、整形外科手術、脳神経手術)分析、地域別分析、競争状況、企業情報など、以下の構成でお届けいたします。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・市場インサイト
・癒着バリアの世界市場規模:製品別(合成癒着バリア、天然癒着バリア)
・癒着バリアの世界市場規模:剤型別(フィルム製剤、液剤、ゲル製剤)
・癒着バリアの世界市場規模:用途別(婦人科手術、一般/腹部手術、心臓血管手術、整形外科手術、脳神経手術)
・癒着バリアの世界市場規模:地域別
・競争状況
・企業情報
【レポートの概要】

“The adhesion barriers market is valued at an estimated USD 529 million in 2020 and is projected to reach USD 769 million by 2025, at a CAGR of 7.8% during the forecast period.” The increasing volume of surgeries and sports-related injuries, rising geriatric population, and the increasing awareness about adhesion formation and adhesion-related diseases are the major factors driving the growth of this market.

“The synthetic adhesion barrier market is projected to witness the highest growth in the adhesion barriers market, by type of products, during the forecast period.”
Based on products, the adhesion barriers market is further segmented into synthetic and natural adhesion barriers. Synthetic adhesion barriers are further classified into hyaluronic acid, regenerated cellulose, polyethylene glycol (PEG), and other synthetic adhesion barriers. The hyaluronic acid-based adhesion barriers segment accounted for the largest share of the synthetic adhesion barriers market. Growth in this segment is driven by the growing preference for hyaluronic acid-based adhesion barriers among surgeons.

“Gynaecological surgeries is the largest application segment of the adhesion barrier market.”
Based on applications, gynecological surgeries held the largest share of the adhesion barriers market in 2019. The large share of this segment can be attributed to factors such as the higher risk of post-surgical adhesion formation in gynecological surgeries, the growing volume of gynecological surgeries, and the availability of several commercialized adhesion barrier products for gynecological surgeries.

“Asia Pacific market to witness the highest growth during the forecast period”
On the basis of region, the adhesion barriers market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Factors such as the rapidly increasing geriatric population, the epidemiological shift from infectious to chronic diseases, and rising medical tourism is expected to drive the growth of this market in the APAC region. Owing to this, the APAC region is expected to grow at a higher CAGR during the forecast period.

Breakdown of primary participants is as mentioned below:
• By Company Type: Tier 1: 42%, Tier 2: 35%, and Tier 3: 23%
• By Designation: C-level Executives: 28%, Directors: 35%, and Others: 37%
• By Region: North America: 33%, Europe: 24%, Asia Pacific: 18%, Latin America: 10%; Middle East: 10%; Africa: 5%

Prominent players in the global adhesion barriers market include Baxter International (US), Johnson & Johnson (J&J) (US), Becton, Dickinson and Company (US), Integra LifeSciences (US), Anika Therapeutics (US), Atrium Medical Corporation (US), FzioMed (US), MAST Biosurgery (Switzerland), Innocoll (Ireland), Betatech Medical (Turkey), CorMatrix Cardiovascular, Inc. (US), Terumo Corporation (Japan), BiosCompass (US), W.L.Gore & Associates (US), and Allosource (US).

Research Coverage:
The report analyzes the adhesion barrier market and estimates the market size and future growth potential of this market based on various segments, such as type of product , formulation, application, and region. It also covers competitive leadership mapping, which helps in analyzing the position of key market players as stars, pervasive players, emerging leaders, and emergin companies. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them to garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global adhesion barrier market. The report analyzes this market by type of product , formulation, application, and region.
• Product Enhancement/Innovation: Detailed insights on upcoming trends and service launches in the global adhesion barrier market.
• Market Development: Comprehensive information on the lucrative emerging markets by type of product , formulation, application, and region.
• Market Diversification: Exhaustive information about new products and services, growing geographies, recent developments, and investments in the global adhesion barrier market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the global adhesion barrier market

【レポートの目次】

1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.2.1 MARKET INCLUSIONS AND EXCLUSIONS 29
1.2.2 MARKETS COVERED 30
1.2.3 YEARS CONSIDERED FOR THE STUDY 30
1.3 CURRENCY 31
TABLE 1 STANDARD CURRENCY CONVERSION RATES 31
1.4 LIMITATIONS 31
1.5 STAKEHOLDERS 31
1.6 SUMMARY OF CHANGES 32
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
FIGURE 1 RESEARCH DESIGN 33
2.1.1 SECONDARY DATA 34
2.1.1.1 Key data from secondary sources 34
2.1.2 PRIMARY DATA 35
FIGURE 2 PRIMARY SOURCES 35
2.1.2.1 Key data from primary sources 36
2.1.2.2 Key industry insights 37
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 37
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION 38
2.2 MARKET SIZE ESTIMATION 38
FIGURE 5 MARKET SIZE ESTIMATION 38
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION 39
FIGURE 7 SUPPLY-SIDE ANALYSIS OF THE ADHESION BARRIERS MARKET 40
FIGURE 8 IMPACT OF COVID-19 ON THE GROWTH RATE (2019–2021) 42
2.2.1 TOP-DOWN APPROACH FOR SUBSEGMENT-LEVEL MARKETS 43
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 44
FIGURE 9 DATA TRIANGULATION METHODOLOGY 44
2.4 MARKET SHARE ESTIMATION 45
2.5 ASSUMPTIONS FOR THE STUDY 45
3 EXECUTIVE SUMMARY 46
FIGURE 10 ADHESION BARRIERS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION) 46
FIGURE 11 SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2020 VS. 2025 (USD MILLION) 47
FIGURE 12 ADHESION BARRIERS MARKET, BY FORMULATION,
2020 VS. 2025 (USD MILLION) 47
FIGURE 13 ADHESION BARRIERS MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 48
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF THE ADHESION BARRIERS MARKET 49
4 PREMIUM INSIGHTS 50
4.1 ADHESION BARRIERS MARKET OVERVIEW 50
FIGURE 15 INCREASING VOLUME OF SURGERIES AND GROWING AWARENESS OF ADHESION BARRIER PRODUCTS ARE DRIVING MARKET GROWTH 50
4.2 ASIA PACIFIC: ADHESION BARRIERS MARKET, BY PRODUCT AND COUNTRY (2019) 51
FIGURE 16 SYNTHETIC BARRIERS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC ADHESION BARRIERS MARKET IN 2019 51
4.3 ADHESION BARRIERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 52
FIGURE 17 CHINA TO REGISTER THE HIGHEST GROWTH RATE DURING
THE FORECAST PERIOD 52
4.4 REGIONAL MIX: ADHESION BARRIERS MARKET (2020−2025) 53
FIGURE 18 NORTH AMERICA WILL CONTINUE TO DOMINATE THE ADHESION BARRIERS MARKET IN 2025 53
4.5 ADHESION BARRIERS MARKET: DEVELOPING VS. DEVELOPED MARKETS 53
FIGURE 19 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 54
5.2.1 DRIVERS 54
5.2.1.1 Rising geriatric population 54
FIGURE 20 GROWTH IN THE GERIATRIC POPULATION, BY REGION, 1980–2050 55
TABLE 2 LIST OF COMMON SPECIALTIES AND PROCEDURES IN OLDER ADULTS 55
5.2.1.2 Increase in the volume of surgeries and sports-related injuries 56
TABLE 3 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGICAL PROCEDURES PERFORMED (2010 VS. 2020) 56
5.2.1.3 Increasing awareness about the medical implications of adhesions 56
5.2.2 RESTRAINTS 57
5.2.2.1 Reluctance of surgeons to use adhesion barriers 57
5.2.2.2 Product recalls 57
5.2.3 OPPORTUNITIES 58
5.2.3.1 Untapped emerging markets 58
5.2.4 CHALLENGES 58
5.2.4.1 Stringent regulations resulting in limited technological innovations 58
5.3 CONNECTED AND ADJACENT MARKETS 59
TABLE 4 ADJACENT AND RELATED MARKETS TO THE ADHESION BARRIERS MARKET 59

6 INDUSTRY INSIGHTS 60
6.1 INTRODUCTION 60
6.2 INDUSTRY TRENDS 60
6.2.1 RISING FOCUS ON GEL-FORM ADHESION BARRIERS FOR SURGERIES 60
TABLE 5 AVERAGE ADHESION FORMATION RATE IN LAPAROSCOPIC SURGERIES 60
6.3 STRATEGIC BENCHMARKING 61
TABLE 6 PRODUCT PORTFOLIO ANALYSIS: NATURAL VS. SYNTHETIC ADHESION BARRIERS 61
TABLE 7 PRODUCT PORTFOLIO ANALYSIS: FILM VS. LIQUID VS. GEL-BASED ADHESION BARRIERS 62
6.4 CLINICAL TRIAL ASSESSMENT 63
TABLE 8 ADHESION BARRIER PRODUCTS CURRENTLY UNDER CLINICAL TRIALS 63
FIGURE 21 ADHESION BARRIER PRODUCT ASSESSMENT, BY APPLICATION AREA, FORMULATION, TYPE, AND LOCATION OF TRIAL
(STUDY START PERIOD—2017 ONWARD) 64
6.5 PARENT MARKET ANALYSIS 65
FIGURE 22 BIOSURGERY MARKET SNAPSHOT 65
6.6 COVID-19 IMPACT ON THE ADHESION BARRIERS MARKET 65
FIGURE 23 IMPACT OF COVID-19 ON THE ADHESION BARRIERS MARKET 66
FIGURE 24 DECLINE IN SALES OF BIOSURGERY DEVICES VS. ALL MEDICAL DEVICES 66
6.7 PORTER’S FIVE FORCES ANALYSIS 67
FIGURE 25 PORTER’S FIVE FORCES ANALYSIS 67
TABLE 9 PORTER’S FIVE FORCES ANALYSIS 68
6.7.1 THREAT OF NEW ENTRANTS 68
6.7.2 THREAT OF SUBSTITUTES 69
6.7.3 BARGAINING POWER OF SUPPLIERS 69
6.7.4 BARGAINING POWER OF BUYERS 69
6.7.5 INTENSITY OF COMPETITIVE RIVALRY 69
7 ADHESION BARRIERS MARKET, BY PRODUCT 71
7.1 INTRODUCTION 72
TABLE 10 ADHESION BARRIERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION) 72
7.2 SYNTHETIC ADHESION BARRIERS 72
TABLE 11 MAJOR BRANDS OF SYNTHETIC ADHESION BARRIERS 72
TABLE 12 SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 73
TABLE 13 SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 74
7.2.1 HYALURONIC ACID 74
7.2.1.1 Preference for hyaluronic acid is high among surgeons owing to its biocompatibility & bioresorbable properties 74
TABLE 14 HYALURONIC ACID-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 75
7.2.2 REGENERATED CELLULOSE 75
7.2.2.1 Regenerated cellulose is used in gynecological surgeries 75
TABLE 15 REGENERATED CELLULOSE-BASED ADHESION BARRIERS MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 76
7.2.3 POLYETHYLENE GLYCOL 76
7.2.3.1 PEG is commonly used in abdominal and peritoneal surgeries 76
TABLE 16 POLYETHYLENE GLYCOL-BASED ADHESION BARRIERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 77
7.2.4 OTHER SYNTHETIC ADHESION BARRIERS 77
TABLE 17 OTHER SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 78
7.3 NATURAL ADHESION BARRIERS 78
TABLE 18 LIST OF NATURAL ADHESION BARRIERS AVAILABLE IN THE MARKET 79
TABLE 19 NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 79
TABLE 20 NATURAL ADHESION BARRIERS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 79
7.3.1 COLLAGEN & PROTEIN 80
7.3.1.1 Collagen & protein accounted for the largest share of the natural adhesion barriers market 80
TABLE 21 COLLAGEN & PROTEIN-BASED ADHESION BARRIERS MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 80
7.3.2 FIBRIN 81
7.3.2.1 Limited clinical evidence restraining the uptake of these natural adhesion barriers 81
TABLE 22 FIBRIN-BASED ADHESION BARRIERS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 81
8 ADHESION BARRIERS MARKET, BY FORMULATION 82
8.1 INTRODUCTION 83
TABLE 23 ADOPTION OF DIFFERENT ADHESION BARRIER FORMULATIONS IN SURGERIES 83
TABLE 24 ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 83
8.2 FILM FORMULATIONS 84
8.2.1 FILM FORMULATIONS ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET 84
TABLE 25 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIER FILMS 84
TABLE 26 FILM-FORM ADHESION BARRIERS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 85
8.3 LIQUID FORMULATIONS 85
8.3.1 LIQUID FORMULATIONS ARE WIDELY USED IN GYNECOLOGICAL,
PELVIC, AND ABDOMINAL SURGERIES 85
TABLE 27 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIER LIQUIDS 86
TABLE 28 LIQUID-FORM ADHESION BARRIERS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 86

8.4 GEL FORMULATIONS 87
8.4.1 PREFERENCE FOR GEL-BASED FORMULATIONS IS GROWING
AMONG END USERS 87
TABLE 29 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIER GELS 87
TABLE 30 GEL-FORM ADHESION BARRIERS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 88
9 ADHESION BARRIERS MARKET, BY APPLICATION 89
9.1 INTRODUCTION 90
TABLE 31 ADHESION BARRIERS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 90
9.2 GYNECOLOGICAL SURGERIES 90
9.2.1 RISING INCIDENCE OF PELVIC AND UTERINE CANCER TO DRIVE THE DEMAND FOR ADHESION BARRIERS IN GYNECOLOGICAL SURGERIES 90
TABLE 32 PERCENT PREVALENCE OF INTRAUTERINE ADHESIONS ACROSS DIFFERENT GYNECOLOGICAL PROCEDURES 91
TABLE 33 COUNTRIES WITH THE HIGHEST C-SECTION RATE (2017) 91
TABLE 34 ADHESION BARRIERS MARKET FOR GYNECOLOGICAL SURGERIES,
BY COUNTRY, 2018–2025 (USD MILLION) 92
9.3 GENERAL/ABDOMINAL SURGERIES 92
9.3.1 ADHESIONS ARE A COMMON COMPLICATION AND OCCUR IN
55–60% OF ALL ABDOMINAL SURGERIES 92
TABLE 35 ADHESION BARRIERS MARKET FOR GENERAL/ABDOMINAL SURGERIES,
BY COUNTRY, 2018–2025 (USD MILLION) 93
9.4 CARDIOVASCULAR SURGERIES 93
9.4.1 ADHESION BARRIERS ARE USED TO PREVENT POSTOPERATIVE COMPLICATIONS IN CARDIOVASCULAR SURGERIES 93
TABLE 36 LIST OF SOME COMMERCIALLY AVAILABLE ADHESION BARRIERS FOR CARDIOVASCULAR SURGICAL APPLICATIONS 94
TABLE 37 ADHESION BARRIERS MARKET FOR CARDIOVASCULAR SURGERIES,
BY COUNTRY, 2018–2025 (USD MILLION) 94
9.5 ORTHOPEDIC SURGERIES 95
9.5.1 GROWING NUMBER OF SPORTS-RELATED INJURIES TO DRIVE THE DEMAND FOR ADHESION BARRIERS IN ORTHOPEDIC SURGERIES 95
TABLE 38 ADHESION BARRIERS MARKET FOR ORTHOPEDIC SURGERIES, BY COUNTRY, 2018–2025 (USD MILLION) 95
9.6 NEUROLOGICAL SURGERIES 96
9.6.1 GEL FORMULATIONS ARE THE MOST WIDELY USED ADHESION BARRIERS
IN NEUROLOGICAL SURGERIES 96
TABLE 39 ADHESION BARRIERS MARKET FOR NEUROLOGICAL SURGERIES,
BY COUNTRY, 2018–2025 (USD MILLION) 96
9.7 RECONSTRUCTIVE SURGERIES 97
9.7.1 HEALTH INSURANCE POLICIES FOR COSMETIC SURGERY PROCEDURES TO AID IN THE INCREASED USE OF ADHESION BARRIERS 97
TABLE 40 ADHESION BARRIERS MARKET FOR RECONSTRUCTIVE SURGERIES, BY COUNTRY, 2018–2025 (USD MILLION) 97

9.8 UROLOGICAL SURGERIES 98
9.8.1 HIGH INCIDENCE OF POSTOPERATIVE ADHESION FORMATION AFTER OPEN UROLOGICAL SURGERIES IN MORE THAN HALF OF THE TOTAL CASES 98
TABLE 41 ADHESION BARRIERS MARKET FOR UROLOGICAL SURGERIES, BY COUNTRY, 2018–2025 (USD MILLION) 98
9.9 OTHER SURGERIES 99
TABLE 42 ADHESION BARRIERS MARKET FOR OTHER SURGERIES, BY COUNTRY,
2018–2025 (USD MILLION) 99
10 ADHESION BARRIERS MARKET, BY REGION 100
10.1 INTRODUCTION 101
TABLE 43 ADHESION BARRIERS MARKET, BY REGION, 2018–2025 (USD MILLION) 101
10.2 REGULATORY ANALYSIS 101
TABLE 44 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING MEDICAL DEVICES 101
TABLE 45 STRINGENCY OF REGULATIONS FOR ADHESION BARRIERS, BY COUNTRY 102
10.2.1 NORTH AMERICA 102
10.2.1.1 US 102
10.2.1.2 Canada 103
10.2.2 EUROPE 104
10.2.3 APAC 105
10.2.3.1 Japan 105
10.2.3.2 China 106
10.2.3.3 India 106
10.3 NORTH AMERICA 107
TABLE 46 US: ARTHROPLASTY PROCEDURAL VOLUME, BY YEAR (N = 1,525,435) 107
TABLE 47 NORTH AMERICA: HEALTHCARE EXPENDITURE, BY COUNTRY (USD BILLION) 107
FIGURE 26 NORTH AMERICA: ADHESION BARRIERS MARKET SNAPSHOT 108
TABLE 48 NORTH AMERICA: ADHESION BARRIERS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 108
TABLE 49 NORTH AMERICA: ADHESION BARRIERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 109
TABLE 50 NORTH AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2018–2025 (USD MILLION) 109
TABLE 51 NORTH AMERICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 109
TABLE 52 NORTH AMERICA: ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 110
TABLE 53 NORTH AMERICA: ADHESION BARRIERS MARKET, BY APPLICATION,
018–2025 (USD MILLION) 110
10.3.1 US 110
10.3.1.1 The US dominated the global market in 2019 110
FIGURE 27 POPULATION AGED 65 YEARS AND ABOVE IN THE US (2014–2060) 111
TABLE 54 US: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET 112
TABLE 55 US: ADHESION BARRIERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 112
TABLE 56 US: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 112
TABLE 57 US: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 113
TABLE 58 US: ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 113
TABLE 59 US: ADHESION BARRIERS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 113
10.3.2 CANADA 114
10.3.2.1 Increasing Caesarean deliveries to drive the demand for adhesion barriers 114
TABLE 60 CANADA: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET 114
TABLE 61 CANADA: ADHESION BARRIERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 115
TABLE 62 CANADA: SYNTHETIC ADHESION BARRIERS MARKET,
BY TYPE, 2018–2025 (USD MILLION) 115
TABLE 63 CANADA: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 115
TABLE 64 CANADA: ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 116
TABLE 65 CANADA: ADHESION BARRIERS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 116
10.4 EUROPE 116
TABLE 66 EUROPEAN COUNTRIES WITH THE HIGHEST C-SECTION RATE (2017) 117
TABLE 67 EUROPE: ADHESION BARRIERS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 117
TABLE 68 EUROPE: ADHESION BARRIERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 117
TABLE 69 EUROPE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 118
TABLE 70 EUROPE: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 118
TABLE 71 EUROPE: ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 118
TABLE 72 EUROPE: ADHESION BARRIERS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 119
10.4.1 GERMANY 119
10.4.1.1 Germany accounted for the largest share of the European
market in 2019 119
TABLE 73 GERMANY: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET 120
TABLE 74 GERMANY: ADHESION BARRIERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 120
TABLE 75 GERMANY: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 120
TABLE 76 GERMANY: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 121
TABLE 77 GERMANY: ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 121
TABLE 78 GERMANY: ADHESION BARRIERS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 121
10.4.2 FRANCE 122
10.4.2.1 Rising number of advanced orthopedic surgeries to support market growth 122
TABLE 79 FRANCE: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET 122
TABLE 80 FRANCE: ADHESION BARRIERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 122
TABLE 81 FRANCE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 123
TABLE 82 FRANCE: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 123
TABLE 83 FRANCE: ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 123
TABLE 84 FRANCE: ADHESION BARRIERS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 124
10.4.3 UK 124
10.4.3.1 UK has witnessed a rise in the number of cardiovascular, gynecological, and orthopedic surgeries 124
TABLE 85 UK: PERCENTAGE SHARE OF AGING POPULATION (2018–2036) 125
TABLE 86 UK: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET 125
TABLE 87 UK: ADHESION BARRIERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 125
TABLE 88 UK: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 126
TABLE 89 UK: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 126
TABLE 90 UK: ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 126
TABLE 91 UK: ADHESION BARRIERS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 127
10.4.4 ITALY 127
10.4.4.1 Rising geriatric population and increasing prevalence of chronic diseases to drive market growth 127
TABLE 92 ITALY: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET 128
TABLE 93 ITALY: ADHESION BARRIERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 128
TABLE 94 ITALY: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 128
TABLE 95 ITALY: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 129
TABLE 96 ITALY: ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 129
TABLE 97 ITALY: ADHESION BARRIERS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 129
10.4.5 SPAIN 130
10.4.5.1 High cost of surgical procedures in Spain to challenge the adoption of adhesion barriers 130
TABLE 98 SPAIN: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET 130
TABLE 99 SPAIN: ADHESION BARRIERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 131
TABLE 100 SPAIN: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 131
TABLE 101 SPAIN: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 131
TABLE 102 SPAIN: ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 132
TABLE 103 SPAIN: ADHESION BARRIERS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 132
10.4.6 REST OF EUROPE 132
TABLE 104 ROE: ADHESION BARRIERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 133
TABLE 105 ROE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 133
TABLE 106 ROE: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 133
TABLE 107 ROE: ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 134
TABLE 108 ROE: ADHESION BARRIERS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 134
10.5 ASIA PACIFIC 134
FIGURE 28 ASIA PACIFIC: ADHESION BARRIERS MARKET SNAPSHOT 135
TABLE 109 ASIA PACIFIC: ADHESION BARRIERS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 136
TABLE 110 ASIA PACIFIC: ADHESION BARRIERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 136
TABLE 111 ASIA PACIFIC: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 136
TABLE 112 ASIA PACIFIC: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 137
TABLE 113 ASIA PACIFIC: ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 137
TABLE 114 ASIA PACIFIC: ADHESION BARRIERS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 137
10.5.1 JAPAN 138
10.5.1.1 Rising geriatric population to increase the number of surgical procedures performed in the country 138
TABLE 115 JAPAN: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET 138
TABLE 116 JAPAN: ADHESION BARRIERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 139
TABLE 117 JAPAN: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 139
TABLE 118 JAPAN: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 139
TABLE 119 JAPAN: ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 140
TABLE 120 JAPAN: ADHESION BARRIERS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 140
10.5.2 CHINA 140
10.5.2.1 The top 3 regional adhesion barrier players account for 80% of the market in China 140
TABLE 121 CHINA: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET 141
TABLE 122 CHINA: ADHESION BARRIERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 141
TABLE 123 CHINA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 142
TABLE 124 CHINA: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 142
TABLE 125 CHINA: ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 142
TABLE 126 CHINA: ADHESION BARRIERS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 143
10.5.3 INDIA 143
10.5.3.1 High prices of adhesion barriers to hinder their
adoption in the country 143
TABLE 127 INDIA: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET 144
TABLE 128 INDIA: ADHESION BARRIERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 144
TABLE 129 INDIA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 144
TABLE 130 INDIA: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 145
TABLE 131 INDIA: ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 145
TABLE 132 INDIA: ADHESION BARRIERS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 145
10.5.4 REST OF ASIA PACIFIC 146
TABLE 133 NEW ZEALAND: REGISTERED JOINT ARTHROPLASTIES CONDUCTED FROM 2010–2017 146
TABLE 134 ROAPAC: ADHESION BARRIERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 146
TABLE 135 ROAPAC: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 147
TABLE 136 ROAPAC: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 147
TABLE 137 ROAPAC: ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 147
TABLE 138 ROAPAC: ADHESION BARRIERS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 148

10.6 LATIN AMERICA 148
TABLE 139 LATIN AMERICA: ADHESION BARRIERS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 149
TABLE 140 LATIN AMERICA: ADHESION BARRIERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 149
TABLE 141 LATIN AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 149
TABLE 142 LATIN AMERICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 150
TABLE 143 LATIN AMERICA: ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 150
TABLE 144 LATIN AMERICA: ADHESION BARRIERS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 150
10.6.1 BRAZIL 151
10.6.1.1 Brazil is the largest market for adhesion barriers in Latin America 151
TABLE 145 BRAZIL: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET 151
TABLE 146 BRAZIL: ADHESION BARRIERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 151
TABLE 147 BRAZIL: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 152
TABLE 148 BRAZIL: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 152
TABLE 149 BRAZIL: ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 152
TABLE 150 BRAZIL: ADHESION BARRIERS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 153
10.6.2 MEXICO 153
10.6.2.1 Rising burden of chronic diseases to drive market growth 153
TABLE 151 MEXICO: KEY MACROINDICATORS FOR THE ADHESION BARRIERS MARKET 154
TABLE 152 MEXICO: ADHESION BARRIERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 154
TABLE 153 MEXICO: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 154
TABLE 154 MEXICO: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 155
TABLE 155 MEXICO: ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 155
TABLE 156 MEXICO: ADHESION BARRIERS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 155
10.6.3 REST OF LATIN AMERICA 156
TABLE 157 ROLATAM: ADHESION BARRIERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 156
TABLE 158 ROLATAM: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 156
TABLE 159 ROLATAM: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 157
TABLE 160 ROLATAM: ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 157
TABLE 161 ROLATAM: ADHESION BARRIERS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 157
10.7 MIDDLE EAST 158
10.7.1 GYNECOLOGICAL AND GENERAL SURGERIES ACCOUNT FOR AROUND HALF OF THE TOTAL SURGERIES PERFORMED IN THE MIDDLE EAST 158
TABLE 162 MIDDLE EAST: ADHESION BARRIERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 158
TABLE 163 MIDDLE EAST: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 159
TABLE 164 MIDDLE EAST: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 159
TABLE 165 MIDDLE EAST: ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 159
TABLE 166 MIDDLE EAST: ADHESION BARRIERS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 160
10.8 AFRICA 160
10.8.1 IMPLEMENTATION OF NATIONAL HEALTH INSURANCE PLANS TO REDUCE DISPARITIES IN CARE PROVIDED IN THE REGION 160
TABLE 167 AFRICA: ADHESION BARRIERS MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 161
TABLE 168 AFRICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 161
TABLE 169 AFRICA: NATURAL ADHESION BARRIERS MARKET, BY TYPE,
2018–2025 (USD MILLION) 161
TABLE 170 AFRICA: ADHESION BARRIERS MARKET, BY FORMULATION,
2018–2025 (USD MILLION) 161
TABLE 171 AFRICA: ADHESION BARRIERS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 162
11 COMPETITIVE LANDSCAPE 163
11.1 INTRODUCTION 163
11.2 MARKET EVALUATION FRAMEWORK 163
FIGURE 29 MARKET EVALUATION FRAMEWORK: ACQUISITIONS WERE THE MOST ADOPTED STRATEGIES 163
11.3 GEOGRAPHIC REACH OF THE TOP PLAYERS (2019) 164
11.4 R&D EXPENDITURE OF THE TOP PLAYERS OPERATING IN THE ADHESION BARRIERS MARKET 164
FIGURE 30 R&D EXPENDITURE (USD MILLION): KEY PLAYERS IN THE MARKET 164
11.5 REVENUE SHARE ANALYSIS (2015–2019) 165
11.6 MARKET SHARE ANALYSIS (2019) 166
11.7 COMPANY EVALUATION MATRIX 167
11.7.1 STARS 167
11.7.2 EMERGING LEADERS 167
11.7.3 PERVASIVE PLAYERS 167
11.7.4 PARTICIPANTS 168

FIGURE 31 ADHESION BARRIERS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019 168
11.8 COMPETITIVE SITUATION & TRENDS 169
11.8.1 ACQUISITIONS 169
11.8.2 PRODUCT LAUNCHES 169
11.8.3 REGULATORY APPROVALS 169
12 COMPANY PROFILES 170
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 BAXTER INTERNATIONAL 170
FIGURE 32 BAXTER INTERNATIONAL: COMPANY SNAPSHOT (2019) 170
12.2 JOHNSON & JOHNSON (ETHICON, INC.) 172
FIGURE 33 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2019) 172
12.3 BECTON, DICKINSON AND COMPANY 174
FIGURE 34 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019) 174
12.4 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 176
FIGURE 35 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2019) 176
12.5 ANIKA THERAPEUTICS 178
FIGURE 36 ANIKA THERAPEUTICS: COMPANY SNAPSHOT (2019) 178
12.6 ATRIUM MEDICAL CORPORATION (A PART OF GETINGE GROUP) 180
FIGURE 37 GETINGE GROUP: COMPANY SNAPSHOT (2019) 180
12.7 TERUMO CORPORATION 182
FIGURE 38 TERUMO CORPORATION: COMPANY SNAPSHOT (2019) 182
12.8 FZIOMED 184
12.9 MAST BIOSURGERY 186
12.10 INNOCOLL HOLDINGS 187
12.11 BETATECH MEDICAL 188
12.12 CORMATRIX CARDIOVASCULAR, INC. 189
12.13 BIOSCOMPASS 190
12.14 W.L. GORE & ASSOCIATES 191
12.15 ALLOSOURCE, INC. 192
12.16 OTHER PLAYERS WITH ADHESION BARRIER PRODUCTS IN THE PIPELINE 193
12.16.1 XLYNK SURGICAL 193
12.16.2 LUNA INNOVATIONS 193
12.16.3 ACTAMAX SURGICAL MATERIAL, LLC 193
12.16.4 ARC MEDICAL DEVICES, INC. 193
12.16.5 CG BIO INC. 194
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

13 APPENDIX 195
13.1 DISCUSSION GUIDE 195
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 200
13.3 AVAILABLE CUSTOMIZATIONS 202
13.4 RELATED REPORTS 202
13.5 AUTHOR DETAILS 203



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[癒着バリアの世界市場予測(〜2025):製品別(再生セルロース、ヒアルロン酸、ポリエチレングリコール、フィブリン、コラーゲン、タンパク質)、種類別(フィルム、ジェル、液体)、用途別(腹部、整形外科、心臓血管、婦人科手術)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆